CHRS
Coherus BioSciences Inc
1.40$
+9.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Investor relations
Report Dates
Investor relations overview for Coherus BioSciences Inc (CHRS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.
Next report
11/05/2026
Last report
08/05/2026
EPS estimate beaten
Full history
13 of 45 quarters (29%)
Last 16 quarters
5 of 16 quarters (31%)
Earnings Call Transcripts
- 08/05/2026 Earnings Call Q2 2026 Open →
- 05/11/2026 Earnings Call Q1 2026 Open →
- 03/09/2026 Earnings Call Q4 2025 Open →
- 11/07/2025 Earnings Call Q3 2025 Open →
- 08/09/2025 Earnings Call Q2 2025 Open →
- 05/12/2025 Earnings Call Q1 2025 Open →
- 03/10/2025 Earnings Call Q4 2024 Open →
- 11/06/2024 Earnings Call Q3 2024 Open →
- 05/09/2024 Earnings Call Q1 2024 Open →
News on This Stock
- 08/28/2026 Coherus Oncology, Inc. (CHRS): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
- 08/17/2026 Coherus Oncology, Inc. (CHRS): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
- 08/17/2026 Coherus Oncology, Inc. (CHRS): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
- 08/05/2026 Coherus Oncology, Inc. (CHRS): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.